Search Results - "SANEKATA, Masaki"
-
1
Post-marketing safety evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir: A drug-use investigation in patients with high risk factors
Published in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (01-10-2016)“…Abstract Peramivir, the only injectable anti-influenza neuraminidase inhibitor medically available in Japan at present, is considered first-line treatment in…”
Get full text
Journal Article -
2
Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir (I): A drug use investigation
Published in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (01-11-2014)“…Abstract Peramivir is the only intravenous formulation among anti-influenza neuraminidase inhibitors currently available. Peramivir was approved for…”
Get full text
Journal Article -
3
Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir (II): A pediatric drug use investigation
Published in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (01-03-2015)“…Abstract Peramivir is the only intravenous formulation among anti-influenza neuraminidase inhibitors currently available. Peramivir was approved for…”
Get full text
Journal Article -
4
Fungal Metabolites. XVI. Structures of New Peptaibols, Trichokindins I-VII, from the Fungus Trichoderma harzianum
Published in Chemical & pharmaceutical bulletin (1994)“…New peptaibols, trichokindins I-VII, have been isolated from the fungus Trichoderma harzianum. Their structures were characterized by spectrometric methods…”
Get full text
Journal Article -
5
Fungal metabolites. XVIII: New membrane-modifying peptides, trichorozins I-IV, from the fungus Trichoderma harzianum
Published in Chemical & pharmaceutical bulletin (1995)“…New membrane-modifying peptides, trichorozins I-IV, have been isolated from conidia of the fungus Trichoderma harzianum. Their amino acid sequences were…”
Get full text
Journal Article -
6
Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir. II: a pediatric drug use investigation
Published in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (01-03-2015)“…Peramivir is the only intravenous formulation among anti-influenza neuraminidase inhibitors currently available. Peramivir was approved for manufacturing and…”
Get full text
Journal Article -
7
Fungal Metabolites. IV. : Synthesis of an Antibiotic Peptide, Trichosporin B-V, from Trichoderma polysporum
Published in Chemical & pharmaceutical bulletin (1990)“…The antibiotic icosapeptide trichosporin B-V, which was isolated from Trichoderma polysporum, was synthesized by assembling five peptide fragments via the N,…”
Get full text
Journal Article -
8
Fungal Metabolities. XVIII. New Membrane-Modifying Peptides, Trichorozins I-IV, from the Fungus Trichoderma harzianum
Published in Chemical & pharmaceutical bulletin (15-03-1995)“…New membrane-modifying peptides, trichorozing I-IV, have been isolated from conidia of the fungus Trichoderma harzianum. Their amino acid sequences were…”
Get full text
Journal Article -
9
Fungal Metabolites. IV
Published in Chemical & pharmaceutical bulletin (01-11-1990)“…The antibiotic icosapeptide trichosporin B-V, which was isolated from Trichoderma polysporum, was synthesized by assembling five peptide fragments via the N,…”
Get full text
Journal Article